Prokaryotic Expression and Monoclonal Antibody Preparation of Chicken Major Histocompatibility Complex Class II Molecules

[ Objective] To prepare the monoclonal antibody against chicken major histocompatibility complex class II molecules （MHC II）. [ Method ] The prokaryotic expression of the gene fragments of exons 2 -6 encoding alpha chain of MHC II and exons 3 -6 encoding beta chain of MHC II were performed based on its protein sequences. After BALB/c mice were immunized with the purified fusion proteins, the mouse spleen cells were fused with mouse myeloma cells SP2/0. Then the positive hybridoma cells were screened and detected by indirect enzyme-linked immunosorbent assay （ELISA）. [ Result] One hybridoma cell strain secreting monoclonal antibody against alpha chain and two strains secreting monoclonal antibody against beta chain were obtained. These three hybridoma cell strains were named as MHC II alpha-4, MHC II betas-2 and MCH II betas-31, respectively. Their titers of ascites in indirect ELISA were 1 ： 256 000, 1 ： 256 000 and 1 ： 1 280 000, respectively. These antibodies could specifically recog- nize MHC II alpha chain or beta chain in western blotting. [ Conclusion] Three obtained hybridoma stains can stably produce the monoclonal antibody against chicken MHC class II molecules.

The SNPs C.513A>T in the MHC B-F gene and rs15001532 in the SPOCK1 gene are associated with Salmonella pullorum disease resistance in chickens

supported by the Earmarked Fund for the Modern Agroindustry Technology Research System, China （CARS-41）;the National High Technology Research and Development Program of China （2011AA100301）

中药复方多糖对不同MHC B-LβⅡ基因型鸡淋巴细胞免疫信号分子表达的影响

试验旨在探讨中药复方多糖对不同MHC B-LβⅡ基因型鸡免疫调节作用的影响。采用PCR-SSCP方法对500只试验鸡进行MHC B-LβⅡ基因分型,采集不同MHC B-LβⅡ基因型鸡的外周血淋巴细胞,分别加入终浓度为200、100、75、50、25、0μg/mL的中药复方多糖共培养24h,收集细胞,采用ELISA方法检测不同MHC B-LβⅡ基因型鸡淋巴细胞培养液中环磷酸腺苷(cAMP)、环磷酸鸟苷(cGMP)、钙离子(Ca^(2+))、一氧化氮(NO)及诱导型一氧化氮合成酶(iNOS)含量。结果显示,与对照组相比,中药复方多糖能显著提高不同MHC B-LβⅡ基因型鸡淋巴细胞培养上清液中cAMP、cGMP、Ca^(2+)、NO和iNOS的含量(P<0.05)。中药复方多糖剂量为50μg/mL时,AA、BC基因型鸡淋巴细胞培养上清液中cAMP、Ca^(2+)、NO和iNOS的含量最高,BC基因型鸡淋巴细胞培养上清液中cGMP的含量最高;中药复方多糖剂量为75μg/mL时,AA基因型鸡淋巴细胞培养上清液中cGMP的含量最高;中药复方多糖剂量为100μg/mL时,BB基因型鸡淋巴细胞培养上清液中cAMP、cGMP、Ca^(2+)、NO和iNOS的含量最高。本试验结果表明,中药复方多糖能不同程度地提高各MHC B-LβⅡ基因型鸡淋巴细胞培养上清液中cGMP、cAMP、NO、Ca^(2+)和iNOS的含量,且不同MHC B-LβⅡ基因型鸡淋巴细胞最适中药复方多糖免疫调节剂量不同。

鸡MHCⅠα和β2m的原核表达与多克隆抗体的制备

为制备MHCⅠ基因工程疫苗的基础材料,构建了鸡MHCⅠ分子重组质粒并进行原核表达,进而制备鸡MHCⅠ分子的多克隆抗体。应用PCR方法,克隆鸡MHCⅠα和β2m基因,构建重组载体pETMHCⅠα和pET-MHCⅠβ2m,经PCR、双酶切和测序鉴定后,将重组质粒在大肠埃希菌Rosetta中进行诱导表达,融合蛋白纯化后,接种昆明小鼠制备多克隆抗体,血清稀释后用免疫印迹法(Western blot)分析。结果表明,鸡MHCⅠα和β2m基因在大肠埃希菌中成功表达,融合蛋白分子质量分别约为52.1ku和33.0ku;制备的鼠抗鸡MHCⅠα和β2m链多克隆抗体,经Western blot检测证实抗体特异性较强,可进一步用于鸡MHCⅠ分子的研究。

鸡MHCⅠ分子单链三聚体真核表达载体的构建和表达

[目的]探索主要组织相容性复合体Ⅰ类分子(Major Histocompatibility Complex,MHCⅠ)提高抗原呈递效率的方法,获得具有免疫学活性的抗原肽-MHCⅠ分子单链三聚体。[方法]采用基因重组技术,通过连接肽(G4S)3将鸡新城疫病毒抗原表位短肽HN(aa346-353)与鸡MHCⅠ(B-F)分子二聚体的编码基因共价串联,构建带有绿色荧光标签蛋白的真核表达载体p EGFP-HN_(346-353)-B-Fβ2m-α。[结果]转染真核细胞293T后,荧光显微镜观察可见,重组融合蛋白HN_(346-353)-B-Fβ2m-α分子三聚体主要表达定位于真核细胞的内膜系统。Western Blot结果表明,在预期蛋白分子量大小位置有明显的特异反应带,重组蛋白与其相应抗体可发生特异性结合反应。[结论]重组质粒能够在真核细胞中表达,且融合蛋白具有良好的生物学活性。

鸡MHC Ⅱ类分子部分基因的原核表达及单克隆抗体的制备与鉴定

[目的]制备鸡MHCⅡ类分子的单克隆抗体。[方法]在分析鸡MHCII类分子蛋白序列基础上,选取鸡MHCⅡα链基因第2～6外显子和β链基因第3～6外显子进行原核表达,以纯化的融合蛋白免疫Balb/c小鼠,取其脾细胞与骨髓瘤细胞SP2/0进行融合,经克隆和间接ELISA筛选阳性细胞株。[结果]共得到1株分泌鸡MHCⅡα链抗体和2株MHCⅡβ链抗体的杂交瘤细胞,分别命名为MHCⅡα-4、Ⅱβ6-2和Ⅱβ6-31,其腹水效价分别为1∶256000、1∶256000和1∶1280000。Western blotting分析表明其特异性强,能与相应蛋白结合。[结论]成功获得了3株稳定分泌抗鸡MHCⅡ类分子抗体的杂交瘤细胞。